The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.c

Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)

Publications

Parthvi R, Persaud T, Chung SY

Risperidone-Associated Acute Eosinophilic Pneumonia.

American journal of therapeutics 2018 May 30;; — 2018 May 30

Rizos E, Tsigkaropoulou E, Lambrou P, Kanakaki M, Chaniotou A, Alevyzakis E, Liappas I

Risperidone-induced acute eosinophilic pneumonia.

In vivo (Athens, Greece) 2013 Sep-Oct;27;651-3 — 2013 Sep-Oct — 651-3

Thornton C, Maher TM, Hansell D, Nicholson AG, Wells AU

Pulmonary fibrosis associated with psychotropic drug therapy: a case report.

Journal of medical case reports 2009 Nov 16;3;126 — 2009 Nov 16 — 126